Pharmaron Beijing Co., Ltd. (SHE:300759)
China flag China · Delayed Price · Currency is CNY
40.90
-0.70 (-1.68%)
Nov 17, 2026, 3:04 PM CST

Pharmaron Beijing Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Net Income
1,7701,6641,7931,6011,3751,661
Depreciation & Amortization
1,1631,1631,049927.17696.18497.92
Other Amortization
106.36106.3696.7581.4269.8879.76
Loss (Gain) From Sale of Assets
4.694.6925.38-0.061.211.37
Asset Writedown & Restructuring Costs
-12.79-12.7976.56-48.03-220.52-55.91
Loss (Gain) From Sale of Investments
50.3550.35-544.76-21.0171.84-285.29
Provision & Write-off of Bad Debts
80.2880.2842.9535.83--
Other Operating Activities
-519.4116.1397.19-25.12318.9-38.39
Change in Accounts Receivable
-280.97-280.97-296.78-480.1-830.63-295.65
Change in Inventory
-344.96-344.96-148.0782.43-120.89-224.88
Change in Accounts Payable
616.18616.18327.67461.34584.09641.74
Change in Other Net Operating Assets
81.5981.5991.11202.22177.1767.53
Operating Cash Flow
2,6923,2212,5772,7542,1432,058
Operating Cash Flow Growth
-16.98%25.01%-6.42%28.50%4.12%24.83%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Capital Expenditures
-2,975-2,669-2,041-2,865-2,950-2,093
Sale of Property, Plant & Equipment
3.841.853.328.113.151.61
Cash Acquisitions
-957.8-1,124-22.63--1,022-1,226
Investment in Securities
-910.14-655.77-675.58557.561,699-2,020
Other Investing Activities
85.7872.99711.2548.8161.1378.79
Investing Cash Flow
-4,753-4,374-2,024-2,251-2,209-5,258

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Long-Term Debt Issued
-2,8661,3224,171589.814,621
Long-Term Debt Repaid
--1,947-5,295-767.08-838.53-300
Lease Payments
-176.15-176.15-201.86-207.95-225.95-141.44
Net Debt Issued (Repaid)
3,113919.44-3,9733,404-248.724,321
Issuance of Common Stock
1,20316.7110.5117.33--
Repurchase of Common Stock
-6.71-6.71-285.91-0.83-393.38-284.06
Common Dividends Paid
-583.68-531.05-542.23-444.79-404.76-284.72
Other Financing Activities
-84.63-21.38-5.8939.76-370.4-91.26
Financing Cash Flow
3,641377-4,7973,915-1,4173,661

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Foreign Exchange Rate Adjustments
-80.31-3.9378.1411.4372.99-45.52
Net Cash Flow
1,499-780.27-4,1664,429-1,410415.78

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Free Cash Flow
-282.94551.97536.02-111.78-807.04-34.78
Free Cash Flow Growth
-2.98%----
Free Cash Flow Margin
-1.77%3.92%4.37%-0.97%-7.86%-0.47%
Free Cash Flow Per Share
-0.160.310.30-0.06-0.45-0.02
Levered Free Cash Flow
407.98-327.6239.6-1,483-1,678-479.46
Unlevered Free Cash Flow
534.57-207.11191.92-1,369-1,573-427.54
Free Cash Flow After Leases
-459.09375.82334.16-319.73-1,033-176.22

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Cash Income Tax Paid
--101.43110.92-54.99-235.22-22
Change in Working Capital
48.8748.87-59.42202.26-169.29197.57